Ionis Pharmaceuticals Inc (NASDAQ:IONS)

42.95
Delayed Data
As of Jun 22
 +0.78 / +1.85%
Today’s Change
39.07
Today|||52-Week Range
65.51
-14.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues214.2M283.7M346.6M507.7M
 
 
 
 
 
Depreciation And Amortization9.4M10.2M9.0M8.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses252.5M349.2M381.6M474.4M
 
 
 
 
 
Research And Development239.5M319.4M341.8M374.0M
 
 
 
 
 
Total Operating Expenses261.9M359.5M390.6M482.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-47.7M-75.8M-44.0M24.9M
 
 
 
 
 
Extraordinary Charge-8.3M0.00-6.3M-8.1M
 
 
 
 
Interest Expense On Debt22.2M36.7M38.8M44.8M
 
 
 
 
 
Other Expenses21.2M20.3M56.0K-3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-54.4M-87.9M-83.6M-23.3M
 
 
 
 
 
Income Taxes-15.4M-372.0K-2.9M-6.0M
 
 
 
 
 
Minority Interest0.000.000.00-11.3M
 
 
Net Income-39.0M-88.3M-86.6M9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS117.7M119.7M120.9M124.0M
 
 
 
 
 
Shares To Calculate EPS Diluted117.7M119.7M120.9M126.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.74-$0.72$0.08
 
 
 
 
 
EPS Diluted-$0.33-$0.74-$0.72$0.08